Measles and BCG shots for moms and toddlers
Treatments studied
Part of Infections clinical trials.
This trial tests whether giving measles and BCG vaccines to mothers and their children after the child turns 12 months is safe and helpful. It specifically looks at women who are not pregnant and meet several health and study-area requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who can become pregnant (fertile age).
- You are not currently pregnant (and able to pass a pregnancy test).
- You have a negative HIV test.
- You live in the Bandim Health Project (BHP) study area and delivered a child who is now 12 months old.
- You are not using contraceptives right now.
- You have no signs of serious illness: no active or recent cancer (within 2 years), no tuberculosis, no weakened immune system, no ongoing infection, and your mid-upper arm measurement is at least 200 mm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving another BCG vaccine (the one for tuberculosis) at the same time as the third DTP shot can help reduce serious infections and deaths in babies in Africa. If your baby is healthy and getting their routine DTP3, this could be an option to possibly boost their overall protection.
This trial offers a measles vaccine to children who have not had full measles shots, timed around visits to a children’s hospital. It aims to see whether vaccinating children at these health care contacts helps improve protection against measles.
This Phase 3 study tests whether MTBVAC can safely protect newborn babies from tuberculosis and whether it helps the baby’s immune system learn to fight TB. If you enroll, the goal is to see safety and immune response in real newborn settings in sub-Saharan Africa.
This Phase 2 study tests MTBVAC, a TB vaccine candidate, to see if it is safe and whether it helps the immune system. It may be a fit if you’re eligible for TB and HIV-related vaccine safety testing and can follow study visits and testing.
This trial tests a way to give HPV vaccines along with routine childhood immunizations in Ghana. It aims to protect against HPV, a virus that can cause cervical cancer, by making it easier to get the vaccine.
This trial tests whether a new vaccine called MTBVAC can prevent tuberculosis (TB) in people living in areas where TB is common. If you are between 14 and 45 years old and in good health, you may be able to join.
Hear when a new Measles trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.